Celgene invests in Quanticel; holds purchase option; option exercised
Celgene Corp. has entered into an exclusive agreement with genomics start-up Quanticel Pharmaceuticals Inc. Celgene committed $45mm in funding during the initial three-and-a-half-year alliance term, took an undisclosed equity stake, and retains an exclusive option to both extend the deal and/or acquire the company.
Drug Discovery Tools
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.